Evidence map›Paper›PMID 18520719›Full record

ReviewCurrent opinion in cardiology2008

Endothelin-1, aging and hypertension.

Brian L Stauffer, Christian M Westby, Christopher A DeSouza

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in cardiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Observational
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Promoting healthy cardiovascular aging: emerging topics.The journal of cardiovascular aging · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. The Role of Histone Protein Acetylation in Regulating Endothelial Function.Frontiers in cell and developmental biology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Brian L StaufferIntegrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, CO 80309, USA.
Christian M Westby
Christopher A DeSouza
University of Colorado Boulder · USDenver Health Medical Center · US

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI KOSMISKI, LISA A. · 1985 to 2008
$52.6M
Obesity/Insulin Resistance, Vitamin C and Endothelin-1R01HL076434 · NHLBI · UNIVERSITY OF COLORADO AT BOULDER · PI DESOUZA, CHRISTOPHER A · 2004 to 2008
$1.5M
Aging, Exercise and Endothelin-1 Vasoconstrictor ToneR01HL077450 · NHLBI · UNIVERSITY OF COLORADO AT BOULDER · PI DESOUZA, CHRISTOPHER A · 2004 to 2007
$1.4M
NCRR NIH HHS M01 RR000051NCRR NIH HHS M01 RR00051NHLBI NIH HHS HL076434NHLBI NIH HHS HL077450NHLBI NIH HHS R01 HL076434NHLBI NIH HHS R01 HL077450
6 · The paper itself

Abstract

purpose of reviewEndothelin-1 system activation plays an important role in the etiology of atherosclerotic vascular disease. Aging and hypertension are two independent cardiovascular risk factors that have been shown to exhibit increased endothelin-1 system activation. This review focuses on the cardiovascular effects of the endothelin system, its relation to aging and hypertension, as well as potential treatment options. RECENT

findingsMany of the cardiovascular complications associated with both aging and hypertension are attributable, in part, to endothelial dysfunction, particularly vasomotor dysregulation. To date most studies have focused on the effects of aging and hypertension on endothelium-dependent nitric oxide-mediated vasodilation. However, endothelin-1-mediated vasoconstrictor tone increases with age and contributes to the pathogenesis of hypertension. Pharmacologic approaches to reduce endothelin-1 system activation have produced limited results and are largely disease-specific. In contrast, regular aerobic exercise has been shown to be extremely effective at reducing endothelin-1 system activity. SUMMARY: Both aging and hypertension represent important cardiovascular disease risk factors that are characterized by increased endothelin-1-mediated vasoconstrictor tone. Future studies are needed to elucidate pharmacologic options for reducing endothelin-1 system activity especially in older hypertensive adults, though regular aerobic exercise must continue to be a point of emphasis for maintaining/improving vascular health.

Indexed as

AgingAntihypertensive AgentsAspartic Acid EndopeptidasesCalcium Channel BlockersEndothelin-1Endothelin-Converting EnzymesEndothelin Receptor AntagonistsEndothelium, VascularExerciseHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypertensionMetalloendopeptidasesMuscle, Smooth, VascularAntihypertensive AgentsAspartic Acid EndopeptidasesCalcium Channel BlockersEndothelin-1Endothelin-Converting EnzymesEndothelin Receptor AntagonistsHydroxymethylglutaryl-CoA Reductase InhibitorsMetalloendopeptidases

Identifiers

PMID18520719
PMCPMC2430763
OpenAlexW1978924431

What OpenQuestion holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.